Additionally, γδ T cells can target tumor cells by employing mechanisms like engaging death ligands [e.g. TNF-related apoptosis-inducing ligand (TRAIL) and Fas ligand (FasL)] and NK receptors (e.g. NKG2D) (72). Here, KLRK1 is linked to neoplasm.